Keith,
You appear to be a very forthright person. I was on that conference call (I believe Tony Butler hosted it) and remember someone specifically asking you about your credentials in the area of treatment for HIV. Your reponse, if I recall correctly, was that you were not an HIV/AIDS specialist, nor did you have any academic papers published. Furthermore, if I recall correctly, you admitted you were not an expert in this field.
Now, you have turned your attention to ED. You continue to cite the ED conference in Los Angeles as where you obtained your data, but once again I'm going to shoo that notion away. For others, Raymond Rosen (a psychologist who likes people to refer to him as a Dr. Ray Rosen), inventor of the IIEF questionnaire, addressed the attendees on Zonagen's behalf. Rosen is a paid consultant to Zonagen, testing their Vasomaxine (indication for women suffering from ??). In his presentation, Ray specifically discussed the half life of Vasomax/phentolamine po in the blood stream. In fact, he specifically addressed the pharmacokinetics of Vasomax/phentolamine po when he stated that "this is pretty close to the perfect pharmacokinetic profile." While I disagree with Ray, he did state this as fact. Keith, you really are going to have to go back to your employer and ask for help in this matter.
Lastly, Rosen did not present the entire data at this conference. If you were really present, then you would know that he presented a substantial amount of data on the parallel designed study (40% efficacy vs. 17% placebo), but little information on the crossover study (34% efficacy vs. 21% placebo).
Really, I must ask again. What on earth are you doing in this forum misleading people?
Tokyo |
